Australia · Delayed Price · Currency is AUD Neuren Pharmaceuticals Statistics
Total Valuation
ASX:NEU has a market cap or net worth of AUD 2.66 billion. The enterprise value is 2.38 billion.
| Market Cap | 2.66B |
| Enterprise Value | 2.38B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Sep 15, 2026 |
Share Statistics
ASX:NEU has 126.77 million shares outstanding.
| Current Share Class | 126.77M |
| Shares Outstanding | 126.77M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -4.05% |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 22.86% |
| Float | 109.86M |
Valuation Ratios
The trailing PE ratio is 134.82 and the forward PE ratio is 41.96.
| PE Ratio | 134.82 |
| Forward PE | 41.96 |
| PS Ratio | 38.33 |
| PB Ratio | 7.99 |
| P/TBV Ratio | 7.99 |
| P/FCF Ratio | 524.87 |
| P/OCF Ratio | 520.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 171.24, with an EV/FCF ratio of 468.44.
| EV / Earnings | 117.40 |
| EV / Sales | 34.21 |
| EV / EBITDA | 171.24 |
| EV / EBIT | 171.57 |
| EV / FCF | 468.44 |
Financial Position
The company has a current ratio of 46.45
| Current Ratio | 46.45 |
| Quick Ratio | 44.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.17% and return on invested capital (ROIC) is 22.36%.
| Return on Equity (ROE) | 6.17% |
| Return on Assets (ROA) | 2.58% |
| Return on Invested Capital (ROIC) | 22.36% |
| Return on Capital Employed (ROCE) | 4.16% |
| Weighted Average Cost of Capital (WACC) | 12.98% |
| Revenue Per Employee | 8.69M |
| Profits Per Employee | 2.53M |
| Employee Count | 8 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASX:NEU has paid 6.56 million in taxes.
| Income Tax | 6.56M |
| Effective Tax Rate | 24.45% |
Stock Price Statistics
The stock price has increased by +8.53% in the last 52 weeks. The beta is 1.59, so ASX:NEU's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | +8.53% |
| 50-Day Moving Average | 18.56 |
| 200-Day Moving Average | 15.87 |
| Relative Strength Index (RSI) | 48.90 |
| Average Volume (20 Days) | 690,427 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:NEU had revenue of AUD 69.53 million and earned 20.26 million in profits. Earnings per share was 0.16.
| Revenue | 69.53M |
| Gross Profit | 20.61M |
| Operating Income | 13.86M |
| Pretax Income | 26.81M |
| Net Income | 20.26M |
| EBITDA | 13.89M |
| EBIT | 13.86M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 286.54 million in cash and no debt, with a net cash position of 286.54 million or 2.26 per share.
| Cash & Cash Equivalents | 286.54M |
| Total Debt | n/a |
| Net Cash | 286.54M |
| Net Cash Per Share | 2.26 |
| Equity (Book Value) | 333.38M |
| Book Value Per Share | 2.63 |
| Working Capital | 326.32M |
Cash Flow
In the last 12 months, operating cash flow was 5.12 million and capital expenditures -40,000, giving a free cash flow of 5.08 million.
| Operating Cash Flow | 5.12M |
| Capital Expenditures | -40,000 |
| Depreciation & Amortization | 26,000 |
| Net Borrowing | n/a |
| Free Cash Flow | 5.08M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 29.64%, with operating and profit margins of 19.94% and 29.14%.
| Gross Margin | 29.64% |
| Operating Margin | 19.94% |
| Pretax Margin | 38.57% |
| Profit Margin | 29.14% |
| EBITDA Margin | 19.97% |
| EBIT Margin | 19.94% |
| FCF Margin | 7.30% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.43%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 1.43% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.43% |
| Earnings Yield | 0.76% |
| FCF Yield | 0.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ASX:NEU is 25.79, which is 26.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 25.79 |
| Price Target Difference | 26.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 34.19% |
| EPS Growth Forecast (3Y) | 32.95% |
Stock Splits
The last stock split was on November 21, 2017. It was a reverse split with a ratio of 0.05.
| Last Split Date | Nov 21, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
ASX:NEU has an Altman Z-Score of 172.71 and a Piotroski F-Score of 4.
| Altman Z-Score | 172.71 |
| Piotroski F-Score | 4 |